By Editor , 27 October 2026

LUND, Sweden – October 27, 2026 -- Alfa Laval's third-quarter order intake rose 36 percent to SEK 23.2 billion (17.1), with organic growth of 33 percent, while the company guided to somewhat lower demand in the fourth quarter.

Sales grow 8 percent as margin narrows to 18.1 percent

Net sales increased 8 percent to SEK 18,596 million (17,244), up 6 percent organically. Adjusted EBITA rose 6 percent to SEK 3,364 million (3,180). The adjusted EBITA margin slipped to 18.1 percent from 18.4 percent a year earlier.

By Editor , 27 October 2026

Hamilton, Bermuda – October 27, 2026 -- Flex LNG Ltd will release unaudited second-quarter 2026 financial results on Wednesday, August 19, 2026, on or about 07:00 CEST (1:00 a.m. EST).

Flex LNG schedules live webcast for 15:00 CEST on results day

The company will hold a live video webcast at 15:00 CEST (9:00 a.m. EST) on the same day, eight hours after the release. Participants must register in advance, and Flex LNG advises doing so 5-10 minutes before the start.

By Editor , 27 October 2026

Hamilton – October 27, 2026 -- Flex LNG Ltd. reported second-quarter 2026 vessel operating revenues of $106.8 million, up from $80.5 million in the first quarter, and net income of $44.9 million, compared with $19.5 million in the prior quarter.

Basic earnings per share reached $0.83 (Q1: $0.36). Adjusted EBITDA rose to $79.0 million from $53.2 million, while adjusted net income climbed to $42.5 million from $16.9 million. Adjusted basic EPS came in at $0.79 versus $0.31, an increase of 155%.

By Editor , 27 October 2026

Tampa – October 27, 2026 -- Akari Therapeutics (Nasdaq: AKTX) reported a second-quarter 2026 net loss of $4.8 million, up from $1.9 million a year earlier, as research and development spending tripled to $2.1 million ahead of a planned Phase 1 start for its lead antibody drug conjugate (ADC), AKTX-101, in mid-2027.

By Editor , 27 October 2026
Southwest Airlines Prices $1.25B Senior Notes Offering

DALLAS – October 27, 2026 -- Southwest Airlines Co. (NYSE: LUV) priced an underwritten public offering of $1.25 billion in senior notes, split across two fixed-rate tranches maturing in 2029 and 2031.

Southwest splits the offering into $600 million at 5.750% and $650 million at 6.000%

The 2029 Notes total $600 million and carry a 5.750% rate. The 2031 Notes total $650 million and carry a 6.000% rate. The offering is expected to close on or about November 2, 2026, subject to customary closing conditions.

By Editor , 27 October 2026
Sands China Plans USD Notes to Refinance $700M 2.300% Debt

LAS VEGAS – October 27, 2026 -- Sands China Ltd. plans to issue USD-denominated senior unsecured notes to redeem in full its outstanding US$700 million 2.300% senior notes due 2027, parent company Las Vegas Sands Corp. (NYSE: LVS) said.

By Editor , 27 October 2026
Energy Fuels Wins A$180M Conditional Backing for Donald Rare Earths

DENVER – October 27, 2026 -- Export Finance Australia (EFA) and the National Reconstruction Fund Corporation (NRFC) have conditionally approved up to A$180 million (US$126 million) for Energy Fuels' Donald Rare Earth and Mineral Sands Project in Victoria, Australia. The commitment is part of a proposed A$200 million senior project finance debt facility for Phase 1 construction. Energy Fuels now targets a final investment decision (FID) by the end of 2026.

By Editor , 27 October 2026
Meta Prices $25B Stock Offering, $12.5B Mandatory Convertible Deal

MENLO PARK – October 27, 2026 -- Meta Platforms raised the size of its Class A common stock offering to $25.0 billion from $22.5 billion and priced a parallel offering of 6.50% mandatory convertible preferred stock expected to net about $12.5 billion.

By Editor , 27 October 2026

PONTE VEDRA – – October 27, 2026 -- Cadrenal Therapeutics (Nasdaq: CVKD) has agreed to raise $3 million in gross proceeds from a single healthcare-focused institutional investor. Warrants could bring in about $5.8 million more if exercised in full for cash.

By Editor , 27 October 2026

PONTE VEDRA – October 27, 2026 -- Cadrenal Therapeutics (Nasdaq: CVKD) has launched a structured partnering process for three cardiovascular assets while holding about $4.2 million in cash, enough to fund operations only through the first quarter of 2027.